Haematology Research Review, Issue 94

In this issue:

Disease risk stratification system for haematological malignancies
BCR-ABL1-negative chronic MPN and pulmonary hypertension
Long-term ibrutinib in symptomatic, previously treated Waldenström macroglobulinaemia
Autologous SCT for progressive systemic sclerosis
Mortality in chronic-phase CML treated with second-generation TKIs
Post-transplant cyclophosphamide vs. antithymocyte globulin-based GVHD prophylaxis
Pomalidomide for patients failing prior chronic GVHD therapy
Copanlisib for relapsed/refractory MZL
Impact of COVID-19 pandemic on SCT and CAR T-cell therapy
Del6q in Waldenström macroglobulinaemia: time to transformation and survival

Please login below to download this issue (PDF)